Sign in to view content

ENVISION Trial 24-Week Data: Phase 2 Study of UBX1325, a New Senolytic Agent for Patients With Wet AMD

Raj K. Maturi, MD

Video
Published 2023

Related

Chronical Submacular Hemorrhage in the Setting of Neovascular AMD
Rita Couceiro, MD, MS
carlos marques-neves, MD, PhD, EBO
Retina Image Bank: Images of the Week
2015
Assessing Supplemental Injection Use Across Groups in the Phase 2 DAVIO 2 Trial of EYP-1901 vs Aflibercept in Wet Age-Related Macular Degeneration
Veeral S. Sheth, MD, MBA, FASRS, FACS
Annual Meeting Talks
2024
Episode 158: Journal Club with Dr. Ajay Kuriyan and Dr. Shriji Patel, IVR versus IVA for wet AMD, Protocol T subanalysis, CSR natural history
Jayanth Sridhar, MD
Member Podcasts
2018

Category: AMD-Neovascular

See more